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valvular lesions and those with echocardiographic evidence of
valvular lesions.
Results: Carditis was diagnosed clinically in 56% whereas 2D Echo
Doppler done in all patients with suspicion of RF, RHD increased
the sensitivity of detection of RF/Carditis to 90.6%. Also the
specificity and positive predictive value of 2D Echo Doppler was
100%. In our study clinically only 25.5% patients were diagnosed to
have different types of valvular lesions by auscultation and ECG
against which 48% patients were diagnosed and proved by echo-
cardiography to have RF & RHD.
Conclusion: Echocardiography increases yield of RF & RHD in
patients with acute rheumatic fever (p value>.0138) and is also
helpful in mixed valve lesions to determine severity of each
lesion. Subclinical cases of RF can be picked up with Echo Doppler
so that timely treatment and prevention can reducemorbidity and
mortality.
Predictive value of D-dimer levels and tissue
Doppler mitral annular systolic velocity for
detection of left atrial appendage thrombus in
patients with mitral stenosis
K. Naresh, D. Rajasekhar, V. Vanajakshamma, D. Sarath
Sri Venkateswarwa Institute of Medical Sciences, Tirupati, India
Background: Left atrial appendage (LAA)thrombus is one of
causative factor for thromboembolic events in patient with mitral
stenosis(MS).Several biochemical and echocardiographic param-
eters have been suggested to predict the presence of LAA
thrombus in these patients.
Aims: 1)To assess the predictive value of mitral annular systolic
velocity(S-wave)andD-dimer for the detection of LAA thrombus in
patients with MS in sinus rhythm(SR).2)To correlate D-dimer
levels with LAA spontaneous echo contrast(SEC) and LAA
thrombus.
Methods: Total 59 patients with symptomatic MS in SR were
evaluated by transthoracic and transesophageal echocardiogra-
phy and divided into 2groups. Patients with LAA thrombus (n¼7)
and without LAA thrombus(n¼52).Plasma concentrations of the
D-dimer were measured with Roche Cardiac reader in both the
groups.
Results: Patient with LA/LAA thrombus had higher rates of heart
failure than those without thrombus (28.57%, p<0.01).Thrombus
group had significantly lower mitral annular S-wave veloc-
ities(7.42±1.1cm/s, Vs10.78±1.3, p<0.001)and higher D-dimer lev-
els(824±258Vs270±94,p<0.001) than those without thrombus.The
LAA late emptying velocity (Lev) showed significant positive cor-
relation with S-wave (r¼0.54, p<0.0001)and moderate to severe
SEC(r¼0.44, p<0.001)and a significant negative correlation with
the D-dimer levels(r¼0.45, P<0.0004).Multivariate analysis
revealed that D-dimer,LAA Lev,S-wave velocity were independent
predictors of LAA thrombi. ROC analysis yielded an optimal D-
dimer cutoff value of 400mg/L for prediction of LAA thrombi with
sensitivity of 87.5%,specificity of 94%,positive predictive value of
83%and negative predictive value of 95%while S wave of 8cm/s
predicted LAA thrombus with sensitivity of 84.6%,specificity of
71.4%and positive predictive value of 50% and negative predictive
value of 93.3%.
Conclusions: D-dimer and S wave velocity are independent pre-
dictors of LAA thrombus in MS patients with SR. Both have higher
negative predictive values.
N-Terminal-proBNP [NT-proBNP], a surrogate
biomarker of combined clinical and hemodynamic
outcomes following PTMC
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Background: Natriuretic peptides (NP) have been evaluated in the
setting of valvular heart diseases. This present study is designed
to examine the relationship between plasma levels of NT-proBNP
and various echocardiographic, hemodynamic parameters in pa-
tients with MS undergoing PTMC.
Methods: The study population consisted of 100 patients with
rheumatic MS who underwent PTMC between June 2012 and
November 2013. 2 ml of blood sample was collected by venipunc-
ture into heparinised tubes 30 min before and 48 h after PTMC.
Results: Most of the study population were females. The male to
female ratio was 19 : 81. Mean age of the study populationwas 37.5
+ 11 years ranging between 13 - 63 years. On correlation with
various echocardiographic parameters, it was observed that log
NT-proBNP correlated significantly with LA volume (r¼0.38;
p<0.01) and LAVI (r¼0.45; p<0.01). On correlation with various
hemodynamic parameters, it was observed that log NT-proBNP
showed significant correlation with systolic PA pressures (r¼0.42;
p<0.01) and mean PA pressures (r¼0.41; p<0.01).
Ninety two patients underwent successful PTMC. Four patients
developed moderate - severe mitral regurgitation (MR) and four
others developed AF (lasting >24hours) following PTMC. NT-
proBNP levels decreased significantly following PTMC (p<0.01). A
significant decrease in NT-proBNP levels was observed both in
patients with AF (p <0.05) and also in those with SR (p <0.01) (Table
6).
Conclusions: This present study demonstrated that NT-proBNP
levels were significantly elevated in patients with severe MS. NT
proBNP levels decreased significantly following PTMC along with
improvement in various echocardiographic and hemodynamic
parameters. Decrease in NT-proBNP levels following PTMC
correlatedwith decrease in LA volume, LAVI, systolic PA pressures
and mean PA pressures.
Calculation of Time in Therapeutic Range (TTR) in
valve clinic follow up patients with mechanical
heart valve replacement
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Sri Venkateswara Institute of Medical Sciences, Tirupati, India
Background: High quality lifelong oral anticoagulation (LOAC)
therapy after valve replacement using a mechanical valve is
necessary for prevention of thromboembolism and hemorrhagic
complications.One quality measure of anticoagulation manage-
ment is analyzing individual time in therapeutic range (TTR), but
still there are no studies about optimal TTR value in mechanical
heart valve patients.This studywas selected to analyze role of TTR
in LOAC therapy receiving mechanical heart valve patients.
Aims: To calculate and to correlate TTR with a) prosthetic valve
thrombosis (PVT), b) cerebral embolism (CE), total embolic events
(TEE), c) major-moderate bleeding events (MBE), total bleeding
events (TBE) in patients with mechanical prosthetic valves.
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Methods: In this prospective observational study prospectively
observed events were only included. The Rosendaal linear inter-
polation methodology was used for calculation of TTR.Based on
individual TTR all patients were categorized into 4 quartiles, 1st
quartile (<51%), 2nd quartile(51-58.15%), 3rdquartile(58.15-
66.55%), highest quartile (>66.55%) all events distribution was
compared with quartiles.
Results: Total of 256 patients were followed for 461 pt years. Pa-
tients in 1st quartile,had significantly higher risk of PVT(OR-22.78,
P¼0.0028),TEE(OR-9, P¼0.041),and TBE(OR-26, P¼0.0017)than
highest quartile, whereas no significant difference for CE, MBE
between 1stquartile and highest quartile. Patients in 2nd quartile
had significantly higher risk for only TBE (OR-9, p<0.041) than
highest quartile.PVT, TEE, TBE risk is significantly higher in lowest
quartiles(<51%) whereas only risk of TBE is higher in 2nd quarti-
le.There is no significant difference between 3rd and 4th quartiles
for any event.
Conclusion: In patients with mechanical valve on LOAC therapy
risk of events like PVT,TEE,TBE, correlates with low
TTR<51%,whereas only TBE correlates with low TTR<58.15% thus
optimal TTR for them is ABOVE 58%.Thus TTR can be used to
predict risk of events like PVT,TEE,TBE in mechanical heart valve
patients.
Tricuspid and pulmonary valve involvement in
rheumatic heart disease
K.R. Patil, S. Prabhu, N.O. Bansal
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Background: Right-sided valve abnormalities are less common
than their left-sided counterparts. Furthermore, whilst organic
rheumatic involvement of the tricuspid valve is not uncommon, it
receives less attention than left-sided heart valves & frequently
missed on routine clinical examination. Our aim was to study the
prevalence of tricuspid and pulmonary valve involvement in
rheumatic heart disease.
Methods: We prospectively studied 713 patients of rheumatic
valvular heart disease from January 2011 to june 2014.Tricuspid
and pulmonary valve was examined echocardiographically for
stenosis and regurgitation.The severity was graded according to
ASE guidelines.
Results: Among 713 patients of rheumatic heart disease stud-
ied,mitral valve involment was seen in 77% patients,aortic valve
involvement in 56% patients while both mitral and aortic
involvement was seen in 49% of patients.Among these pa-
tients,122 (17.11%) had organic tricuspid valve disease.In this 71
(58.19%) were females and 51 (41.8%) weremales.Out of these total
122 patients, 78 (63.93%) had isolated tricuspid regurgitation, 44
(36.06%) had tricuspid stenosis with or without tricuspid regurgi-
tation. 6 (4.91%) patients had isolated tricuspid valve stenosis.
Functional tricuspid regurgitation was found in 406 (56.94)%
patients.From total number of patients with organic TR ,19
(15.57%) had mild;68 (55.73 %) had moderate and 35 (28.68%) had
severe tricuspid regurgitation.There was no single patient with
organic pulmonary valve involvement.
Conclusions: We conclude that Rheumatic tricuspid valve disease
is not uncommon among patients with rheumatic heart disease,
but attracts less attention and might, therefore, be overlooked.
Echocardiography is the most common diagnostic tool and is
must for further management.Pulmonary valve involvement is
very rare.Appropriate treatment of the tricuspid valve disease,-
even when secondary to left heart diseases,may improve long
term outcome.
Treatment and outcome of obstructive
thrombosed prosthetic heart valves from a tertiary
care hospital
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Background: Obstructive thrombosed prosthetic heart valve
(OTPHV) is a serious complication of mechanical heart valve
replacement. There are no generally accepted criteria for man-
agement of these patients with obstructed prosthetic valves. In
the present study we aimed to study the 30 day outcome of pa-
tients who presentedwith obstructed prostheticmechanical heart
valves to a tertiary care hospital.
Methods: A total of 22 consecutive patients presenting with 27
instances of PHVT were included in the study between and 2013
and 2014. The diagnosis of PHVT was established mainly by
echocardiography by increased mean gradients across the pros-
thetic valve. The fibrinolytic agents used were streptokinase (STK)
in 16 PHVT episodes and urokinase (UK) in 2 cases, 8 cases were
directly referred to redo valve replacement surgery and 4 cases
were referred to surgery after failed fibrinolytic therapy. One pa-
tient had 4 episodes of PHVT and shown improvement with
fibrinolysis each time, and two patients had 2 episodes of PHVT.
The efficacy of Fibrinolytic therapy or surgery was assessed from
hemodynamic parameters derived from echocardiographic ex-
aminations as well as on clinical grounds and 30 day outcomes
were analyzed.
Results: Among the 22 cases of PHVT 18 cases were involving the
mitral valves only 4 cases were aortic mechanical prosthetic heart
valves. Death occurred in 6 cases of 18 cases (33%) who were
treated with fibrinolytic therapy with in 1 week of admission to
the hospital and 4 PHVT episodes has shown only partial
improvement and they were referred to the surgery. Death
occurred in 3 cases of 12 cases (25%) who underwent redo pros-
thetic valve replacement .There were 4 documented embolic ep-
isodes occurred in the fibrinolytic group . No hemorrhagic
episodes were documented.
Conclusions: These results indicate that redo surgical prosthetic
valve replacement has a reducedmortality and complications rate
in comparison to fibrinolytic therapy in patients with obstructed
prosthetic heart valves.
Prevalence of coronary artery disease in patients
with rheumatic and non-rheumatic valvular heart
disease treated at Asian heart hospital, Mumbai
A. Amale, S. Dora
Asian Heart Institute and Research Centre Private Limited, Mumbai,
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Background: Although coronary artery disease (CAD) is the most
common cause cardiovascular mortality worldwide but rheu-
matic heart disease (RHD) still continues to be one of themajor CV
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